Laboratory Investigation of Myeloproliferative Neoplasms (MPNs)

被引:0
作者
Busque, Lambert [1 ]
Porwit, Anna [2 ,3 ]
Day, Radmila [5 ]
Olney, Harold J. [6 ]
Leber, Brian [7 ]
Ethier, Vincent [1 ]
Sirhan, Shireen [8 ]
Foltz, Linda [9 ]
Prchal, Jaroslav [10 ]
Kamel-Reid, Suzanne [2 ,3 ]
Karsan, Aly [11 ,12 ]
Gupta, Vikas [4 ]
机构
[1] Univ Montreal, Hop Maisonneuve Rosemont, Dept Lab Hematol, 5415 Blvd Assompt, Montreal, PQ H1T 2M4, Canada
[2] Univ Toronto, Princess Margaret Canc Ctr, Dept Pathol, Univ Hlth Network, Toronto, ON, Canada
[3] Univ Toronto, Princess Margaret Canc Ctr, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[4] Univ Toronto, Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada
[5] Fus MD Med Sci Network, Montreal, PQ, Canada
[6] Ctr Hosp Univ Montreal, Dept Hematol & Transfus Med, Montreal, PQ, Canada
[7] McMaster Univ, Dept Med Hematol & Thromboembolism, Hamilton, ON, Canada
[8] Jewish Gen Hosp, Div Hematol, Montreal, PQ, Canada
[9] Univ British Columbia, St Pauls Hosp, Div Hematol, Vancouver, BC, Canada
[10] McGill Univ, Div Oncol, Montreal, PQ, Canada
[11] BC Canc Agcy, Pathol & Lab Med, Vancouver, BC, Canada
[12] BC Canc Agcy, Michael Smith Genome Sci Ctr, Vancouver, BC, Canada
关键词
Myeloproliferative neoplasms; Myelofibrosis; Polycythemia vera; Essential thrombocythemia; JAK2; V617F; CALR; MPL; BCR-ABL negative; EXON; 12; MUTATIONS; ERYTHROID COLONY FORMATION; TYROSINE KINASE JAK2; POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; PRIMARY MYELOFIBROSIS; DIAGNOSTIC-CRITERIA; SOMATIC MUTATIONS; CLONAL HEMATOPOIESIS; MOLECULAR DIAGNOSIS;
D O I
10.1093/AJCP/AQW131
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objectives: To standardize diagnostic investigations for myeloproliferative neoplasms (MPNs) to increase homogeneity in patient care and to streamline diagnostic approaches in the most efficient and cost-effective manner. Methods: The development of Canadian expert consensus recommendations for the diagnosis of MPNs began with a review of the following: clinical evidence, daily practice, existing treatment guidelines, and availability of diagnostic tools. Each group member was assigned a specific topic, which they discussed with the entire group during several consensus meetings. Results: This document provides the Canadian MPN group's recommendations, proposed diagnostic algorithms, and background evidence upon which decisions were made. Conclusions: Standardization of diagnostic investigations will increase homogeneity in patient care and provide a foundation for future clinical research in this rapidly evolving therapeutic area. Streamlining diagnostic approaches in the most efficient and cost-effective manner will also result in significant cost saving for the health care system.
引用
收藏
页码:408 / 422
页数:15
相关论文
共 90 条
[1]   The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia [J].
Arber, Daniel A. ;
Orazi, Attilio ;
Hasserjian, Robert ;
Thiele, Jurgen ;
Borowitz, Michael J. ;
Le Beau, Michelle M. ;
Bloomfield, Clara D. ;
Cazzola, Mario ;
Vardiman, James W. .
BLOOD, 2016, 127 (20) :2391-2405
[2]  
Bai J, 2004, CHINESE MED J-PEKING, V117, P668
[3]   Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis [J].
Barbui, T. ;
Thiele, J. ;
Vannucchi, A. M. ;
Tefferi, A. .
BLOOD CANCER JOURNAL, 2015, 5 :e337-e337
[4]   Rethinking the diagnostic criteria of polycythemia vera [J].
Barbui, T. ;
Thiele, J. ;
Vannucchi, A. M. ;
Tefferi, A. .
LEUKEMIA, 2014, 28 (06) :1191-1195
[5]  
Barbui T., American journal of hematology
[6]   Masked polycythemia vera diagnosed according to WHO and BCSH classification [J].
Barbui, Tiziano ;
Thiele, Juergen ;
Carobbio, Alessandra ;
Gisslinger, Heinz ;
Finazzi, Guido ;
Rumi, Elisa ;
Randi, Maria Luigia ;
Vannucchi, Alessandro M. ;
Gisslinger, Bettina ;
Muellauer, Leonhard ;
Ruggeri, Marco ;
Rambaldi, Alessandro ;
Tefferi, Ayalew .
AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (02) :199-202
[7]   Brief report Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome [J].
Barbui, Tiziano ;
Thiele, Juergen ;
Passamonti, Francesco ;
Rumi, Elisa ;
Boveri, Emanuela ;
Randi, Maria Luigia ;
Bertozzi, Irene ;
Marino, Filippo ;
Vannucchi, Alessandro M. ;
Pieri, Lisa ;
Rotunno, Giada ;
Gisslinger, Heinz ;
Gisslinger, Bettina ;
Muellauer, Leonhard ;
Finazzi, Guido ;
Carobbio, Alessandra ;
Gianatti, Andrea ;
Ruggeri, Marco ;
Nichele, Ilaria ;
D'Amore, Emanuele ;
Rambaldi, Alessandro ;
Tefferi, Ayalew .
BLOOD, 2012, 119 (10) :2239-2241
[8]   Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders [J].
Baxter, EJ ;
Scott, LM ;
Campbell, PJ ;
East, C ;
Fourouclas, N ;
Swanton, S ;
Vassiliou, GS ;
Bench, AJ ;
Boyd, EM ;
Curtin, N ;
Scott, MA ;
Erber, WN ;
Green, AR .
LANCET, 2005, 365 (9464) :1054-1061
[9]   MPL mutations in myeloproliferative disorders:: analysis of the PT-1 cohort [J].
Beer, Philip A. ;
Campbell, Peter J. ;
Scott, Linda M. ;
Bench, Anthony J. ;
Erber, Wendy N. ;
Bareford, David ;
Wilkins, Bridget S. ;
Reilly, John T. ;
Hasselbalch, Hans C. ;
Bowman, Richard ;
Wheatley, Keith ;
Buck, Georgina ;
Harrison, Claire N. ;
Green, Anthony R. .
BLOOD, 2008, 112 (01) :141-149
[10]   Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations [J].
Bench, Anthony J. ;
White, Helen E. ;
Foroni, Letizia ;
Godfrey, Anna L. ;
Gerrard, Gareth ;
Akiki, Susanna ;
Awan, Abida ;
Carter, Ian ;
Goday-Fernandez, Andrea ;
Langabeer, Stephen E. ;
Clench, Tim ;
Clark, Jordan ;
Evans, Paul A. ;
Grimwade, David ;
Schuh, Anna ;
McMullin, Mary F. ;
Green, Anthony R. ;
Harrison, Claire N. ;
Cross, Nicholas C. P. .
BRITISH JOURNAL OF HAEMATOLOGY, 2013, 160 (01) :25-34